ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy

November 30, 1979

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

NCI renews Roswell Park’s core grant for five years.

September 26, 2003

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

Powers, NCI Still Disagree On Organ Systems Provisions

April 22, 1983